Bharat Serums AND Vaccines Limited Serum Export Data — India (DGFT 2022–2026)

Name: Bharat Serums AND Vaccines Limited Serum Export Records India — #1 Exporter, 131 Shipments, $6.5M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Serum

India Pharmaceutical Trade Intelligence

$27.1M341 Suppliers122 CountriesHS 30029090

ExportsIndia → PHILIPPINES20.7%India → THAILAND9.8%

ImportsBRAZIL → India$1.3B AUSTRALIA → India$42.4M

#1 Supplier: BHARAT SERUMS

Bharat Serums AND Vaccines Limited — Serum Exporter #1 | $6.5M Trade Value | TransData Nexus | TransData Nexus

Bharat Serums AND Vaccines Limited — Serum Exporter Profile

Indian Pharmaceutical Exporter · #1 for Serum · $6.5M export value · DGFT Verified

Bharat Serums AND Vaccines Limited is the #1 Indian exporter of Serum with $6.5M in export value and 131 verified shipments. Bharat Serums AND Vaccines Limited holds a 24.1% market share in Serum exports across 29 countries. The company exports 4 pharmaceutical products worth $40.1M across 3 therapeutic categories.

Bharat Serums AND Vaccines Limited — Serum Export Profile: Buyers & Destinations

Bharat Serums AND Vaccines Limited Serum export treemap — buyers and destination countries | TransData Nexus

Where Does Bharat Serums AND Vaccines Limited Export Serum?

Country	Value	Shipments	Share
PHILIPPINES	$1.1M	21	19.7%
ALGERIA	$750.0K	21	14.1%
PAKISTAN	$695.3K	16	13.0%
TUNISIA	$500.0K	10	9.4%

Who Are the Top Buyers of Serum from Bharat Serums AND Vaccines Limited?

Buyer	Country	Value	Orders
HABIB BANK LIMITED	PAKISTAN	$671.2K	15
PHARMACIE CENTRALE DE	TUNISIA	$400.0K	8
BSV BIOSCIENCE PHILS. INC	PHILIPPINES	$350.0K	7
INSTITUT PASTEUR DU MAROC	MOROCCO	$334.2K	9
INSTITUT PASTEUR D ALGERIE	ALGERIA	$300.0K	8
INSTITUT PASTEUR D?ALGERIE	ALGERIA	$250.0K	8
STATE PHARMACEUTICALS CORPORATION	SRI LANKA	$200.0K	4
BSV BIOSCIENCE PHILIPPINES INC	PHILIPPINES	$200.0K	4
BSV BIOSCIENCE PHILIPPHINES INC	PHILIPPINES	$200.0K	4
BGM PHARMACEUTICALS	SOUTH AFRICA	$188.1K	4

Bharat Serums AND Vaccines Limited supplies Serum to 74 buyers globally. The largest buyer is HABIB BANK LIMITED (PAKISTAN), followed by PHARMACIE CENTRALE DE (TUNISIA) and BSV BIOSCIENCE PHILS. INC (PHILIPPINES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Serum Formulations Does Bharat Serums AND Vaccines Limited Export?

Product Description / Formulation	Value	Shipments
EQUIRAB 1000IU/5ML [Rabies Antiserum-Equ	$300.0K	6
EQUIRAB 1000IU/5ML [Rabies Antiserum - Equine]	$250.0K	5
EQUIRAB 1000 IU/5ML [ Rabies Antiserum -Equine]	$234.8K	5
EQUIRAB 1000 IU/ 5ML RABIES ANTISERUM -	$208.0K	7
EQUIRAB 1000 IU/5ML [RABIES ANTISERUM	$200.0K	4
EQUIRAB 1000 IU 5ML RABIES ANTISERUM EQUINE	$199.9K	4
EQUIRAB 1000 IU/5ML [ RABIES ANTISERUM -EQUINE]	$168.9K	4
EQUIRAB 1000 IU 5ML Rabies Antiserum Equine	$155.4K	5
EQUIRAB 1000IU 5ML Rabies Antiserum Equine	$150.0K	3
SNAKE VENOM ANTISERUM Lyophilized	$150.0K	3

Bharat Serums AND Vaccines Limited exports 110 distinct Serum formulations including tablets, capsules, syrups, and combination drugs. The top formulation is EQUIRAB 1000IU/5ML [Rabies Antiserum-Equ with 6 shipments worth $300.0K.

How Does Bharat Serums AND Vaccines Limited Compare to Nearest Serum Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	BHARAT SERUMS AND VACCINES LIMITED ★	$6.5M	131	29	$50.0K
2	VINS BIOPRODUCTS LIMITED	$5.7M	132	34	$43.3K
3	PREMIUM SERUMS AND VACCINES PRIVATE LIMITED	$1.4M	31	21	$46.5K

Bharat Serums AND Vaccines Limited ranks #1 among 341 Indian Serum exporters. Average shipment value of $50.0K compared to the market average of $54.1K. The closest competitors by value are VINS BIOPRODUCTS LIMITED and PREMIUM SERUMS AND VACCINES PRIVATE LIMITED.

Which Indian Ports Ship Serum Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	3,759	25.1%
SAHAR AIR	2,925	19.5%
DELHI AIR	2,682	17.9%
DELHI AIR CARGO ACC (INDEL4)	1,589	10.6%
Bombay Air	1,099	7.3%
Delhi Air	546	3.6%
NHAVA SHEVA SEA (INNSA1)	208	1.4%
HYDERABAD ACC (INHYD4)	118	0.8%

Geopolitical & Trade Policy Impact on Bharat Serums AND Vaccines Limited's Serum Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like BSV. Heightened security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor have led major carriers to alter trade routes, resulting in extended transit times and increased freight rates on key India–Europe shipping lanes. These disruptions can impact the timely delivery of pharmaceutical products, potentially affecting supply chains and customer relationships. (livemint.com)

Conversely, the India–European Union Free Trade Agreement, concluded in January 2026, is poised to eliminate tariffs on Indian pharmaceutical exports to the EU. This development enhances the competitiveness of Indian exporters like BSV in the European market, potentially offsetting some of the logistical challenges posed by current shipping disruptions. (en.wikipedia.org)

Additionally, ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, creating opportunities for Indian manufacturers to increase their market share in the US. BSV's established presence in critical care and biologics positions it well to capitalize on this shift.

Bharat Serums AND Vaccines Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for pharmaceutical exporters. BSV's adherence to stringent quality requirements, including FDA, WHO, and EU GMP standards, has been instrumental in maintaining its export credentials. The company's focus on high-entry-barrier products necessitates continuous investment in quality assurance and regulatory compliance to meet the evolving standards of global markets.

The recent acquisition by Mankind Pharma is expected to bolster BSV's compliance infrastructure, leveraging Mankind's resources to enhance quality systems and ensure sustained adherence to international regulatory expectations.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Serum shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Bharat Serums AND Vaccines Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 199 individual customs records matching Bharat Serums AND Vaccines Limited exporting Serum, covering 110 formulations to 33 countries via 74 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 122+ countries, 897+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Serum

Serum

Bharat Serums AND Vaccines Limited — Serum Exporter Profile

Bharat Serums AND Vaccines Limited — Serum Export Profile: Buyers & Destinations

Where Does Bharat Serums AND Vaccines Limited Export Serum?

Who Are the Top Buyers of Serum from Bharat Serums AND Vaccines Limited?

What Is India's Total Serum Export Value and How Much Does Bharat Serums AND Vaccines Limited Contribute?

What Is the Average Shipment Value for Bharat Serums AND Vaccines Limited's Serum Exports?

How Does Bharat Serums AND Vaccines Limited Compare to Other Indian Serum Exporters?

What Serum Formulations Does Bharat Serums AND Vaccines Limited Export?

How Does Bharat Serums AND Vaccines Limited Compare to Nearest Serum Exporters?

Which Indian Ports Ship Serum Exports?

What Other Other Products Does Bharat Serums AND Vaccines Limited Export?

Serum — Export Intelligence Video

Geopolitical & Trade Policy Impact on Bharat Serums AND Vaccines Limited's Serum Exports

Bharat Serums AND Vaccines Limited — Regulatory Compliance & Quality Standards

About Bharat Serums AND Vaccines Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Serum Export Data from Bharat Serums AND Vaccines Limited

Serum Stats

Company Overview

Top Products by Bharat Serums AND Vaccines Limited

Related Analysis

Need Detailed Export Data?

Data Source